Cited by 216Atherosclerosis and Cardiovascular DiseasesInflammasome and immune disordersPhagocytosis and Immune Regulation

Vascular Smooth Muscle Cell Apoptosis Induces Interleukin-1–Directed Inflammation: Effects of Hyperlipidemia-Mediated Inhibition of Phagocytosis

Open access
Clarke, Murray C.H., Talib, Sara, Figg, Nichola L., Bennett, Martin R.·2010·Circulation Research

Abstract

Rationale : Atherosclerosis is characterized by lipid accumulation in the vessel wall, inflammation, and both macrophage and vascular smooth muscle cell (VSMC) apoptosis. However, whereas VSMC apoptosis in mice with established atherosclerotic plaques or hyperlipidemia increases serum levels of the proatherogenic cytokines monocyte chemotactic protein (MCP)-1, tumor necrosis factor α, and interleukin (IL)-6, the link between hyperlipidemia, apoptosis and inflammation, and the mechanisms by which apoptotic cells promote inflammation in atherosclerosis are unknown. Objective : To determine whether hyperlipidemia affects apoptotic cell clearance, and identify the molecular pathways downstream of VSMC apoptosis that may promote inflammation. Methods and Results : We find that human VSMCs are potent and efficient phagocytes of apoptotic human VSMCs, but phagocytosis is significantly reduced by oxidized low-density lipoprotein in vitro or hyperlipidemia in vivo. Necrotic human aortic VSMCs release IL-1α, which induces IL-6 and MCP-1 production from viable human VSMCs in vitro. In contrast, secondary necrotic VSMCs release both IL-1α and caspase-activated IL-1β, augmenting IL-6 and MCP-1 production. Conditionally inducing VSMC apoptosis in situ in hyperlipidemic SM22α-hDTR/ApoE −/− mice to levels seen in human plaques increases serum MCP-1, tumor necrosis factor α, and IL-6, which is prevented by blocking IL-1. Conclusions : We conclude that VSMC necrosis releases IL-1α, whereas secondary necrosis of apoptotic VSMCs releases both IL-1α and β. IL-1 from necrotic VSMCs induces the surrounding viable VSMCs to produce proinflammatory cytokines. Thus, failed clearance of apoptotic VSMCs caused by hyperlipidemia in vivo may promote the increased serum cytokines and chronic inflammation associated with atherosclerosis.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/circresaha.109.208389

Cites

45 of 45 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Necrotic VSMCs potently drive inflammation via IL1α due to a lack of IL-1R2 that normally binds and inhibits IL-1α.

    “Indeed, necrotic VSMCs potently drive inflammation via IL1α due to a lack of IL-1R2 that normally binds and inhibits IL-1α 133,189 .”

    From Vascular smooth muscle cells in atherosclerosis (2019) · cites this paper as [133]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Clarke, M. C. H., Talib, S., Figg, N. L., & Bennett, M. R.
Affiliations
University of Cambridge (GB)
Venue
Circulation Research
Published
2010-02-05
Volume
106
Issue
2
Pages
363-372
ISSN
  • 0009-7330 (ISSN-L)
  • 1524-4571
OpenAlex
W2071311043
Cited by
216
References
45
Citations by year
2026: 8 · 2025: 12 · 2024: 15 · 2023: 15 · 2022: 22 · 2021: 17 · 2020: 12 · 2019: 14 · 2018: 11 · 2017: 15 · 2016: 10 · 2015: 15 · 2014: 14 · 2013: 8 · 2012: 10
FWCI
4.00
Type
journal article
Language
en
Open access
Locations
  • Circulation Research (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Amgen
  • British Heart Foundation (PG/06/024/20354, RG04/001, FS/09/005/26845)
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
  • Life Sciences › Immunology and Microbiology › Immunology › Phagocytosis and Immune Regulation
Keywords
vascular smooth muscle cell apoptosis, atherosclerosis, inflammation, interleukin-1, IL-1α, IL-1β, necrosis, hyperlipidemia, oxidized LDL, efferocytosis, phagocytosis, MCP-1, interleukin-6, TNF-α, inflammatory cytokines
MeSH terms
Animals, Apolipoproteins E, Cells, Cultured, Humans, Hyperlipidemias, Immunohistochemistry, Inflammation, Mice, Transgenic, Muscle, Smooth, Vascular, Phagocytosis, Blotting, Western, Interleukin-6, Apoptosis, Mice, Knockout, Chemokine CCL2, Myocytes, Smooth Muscle, Intercellular Signaling Peptides and Proteins, Mice, Interleukin-1alpha, Heparin-binding EGF-like Growth Factor

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review